CME Group Inc. (NASDAQ:CME) Rating Changes as of May 17, 2018

May 17, 2018 - By Shelly Brooks

CME Group Inc. (NASDAQ:CME) Corporate Logo
During 2017 Q4 the big money sentiment increased to 1.15. That’s change of 0.14, from 2017Q3’s 1.01. 29 investors sold all, 224 reduced holdings as CME Group Inc. ratio increased. 212 grew stakes while 78 funds amassed stakes. Funds hold 265.76 million shares thus 0.05% less from 2017Q3’s 265.89 million shares.
Moreover, Bradley Foster And Sargent Ct has 0.15% invested in CME Group Inc. (NASDAQ:CME). Robeco Institutional Asset Management Bv holds 0.08% in CME Group Inc. (NASDAQ:CME) or 108,436 shs. Parkside Finance National Bank & Trust And Trust has invested 0.03% of its capital in CME Group Inc. (NASDAQ:CME). 63 are held by Wealthtrust. Partner Fund Mgmt Ltd Partnership holds 1.36% or 392,106 shs in its capital. Cypress Capital Group Inc, a Florida-based fund reported 63,162 shs. Cap Ww Investors invested in 0.99% or 31.30M shs. Nelson Van Denburg Campbell Wealth Management Grp Incorporated Ltd holds 0% or 8 shs. Comerica National Bank, Michigan-based fund reported 84,159 shs. Point72 Asia (Hong Kong) has invested 0.01% in CME Group Inc. (NASDAQ:CME). Glenmede Trust Na holds 65,269 shs or 0.04% of its capital. Barclays Public Limited owns 523,643 shs. Wellington Gp Llp holds 0% of its capital in CME Group Inc. (NASDAQ:CME) for 3,440 shs. Stadion Money Mgmt Ltd Liability Co stated it has 2,835 shs. Hudock Cap Gp Lc holds 150 shs.

CME Group Inc. had 10 sales and 0 insider buys since December 18, 2017. This’s net activity of $9.68 million. On Tuesday, January 9 Pietrowicz John W. sold $1.14 million worth of CME Group Inc. (NASDAQ:CME) or 7,500 shs. GEPSMAN MARTIN J sold $49,287 worth of CME Group Inc. (NASDAQ:CME) on Thursday, February 15. On Monday, February 5 MELAMED LEO sold $1.14M worth of CME Group Inc. (NASDAQ:CME). $387,972 worth of stock was sold by Sammann Derek on Friday, February 2. Shares for $31,982 were sold by Pankau Ronald A. on Wednesday, February 14. $2.61 million worth of stock was sold by Kometer Kevin on Friday, February 2.

CME Group Inc. (NASDAQ:CME) Ratings Coverage

A total of 9 analysts rate CME Group (NASDAQ:CME) as follows: 7 “Buy”, 2 “Hold” and 0 “Sell”. Тherefore 78% are bullish. (NASDAQ:CME) has 15 ratings reports on May 17, 2018 according to StockzIntelligence. On Monday, February 26 Keefe Bruyette & Woods maintained CME Group Inc. (NASDAQ:CME) rating. Keefe Bruyette & Woods has “Hold” rating and $168.0 target. On Friday, February 2 the stock of CME Group Inc. (NASDAQ:CME) has “Overweight” rating given by Barclays Capital. On Wednesday, February 7 the stock has “Buy” rating by Goldman Sachs. On Thursday, March 8 Bank of America maintained the shares of CME in report with “Buy” rating. In Thursday, February 1 report Sandler O’Neill maintained the stock with “Buy” rating. On Friday, February 2 the rating was maintained by Bank of America with “Buy”. On Tuesday, April 10 the rating was maintained by Jefferies with “Buy”. In Friday, March 2 report Sandler O’Neill maintained it with “Buy” rating and $185.0 target. On Thursday, December 21 Keefe Bruyette & Woods maintained the shares of CME in report with “Hold” rating. On Friday, March 9 the stock of CME Group Inc. (NASDAQ:CME) earned “Buy” rating by Jefferies. Listed here are CME Group Inc. (NASDAQ:CME) PTs and latest ratings.

10/04/2018 Broker: Jefferies Rating: Buy New Target: $190.0000 Maintain
10/04/2018 Broker: Bernstein Rating: Outperform New Target: $190 Initiates Coverage On
06/04/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $185 New Target: $197 Maintain
09/03/2018 Broker: Jefferies Rating: Buy New Target: $187.0 Maintain
08/03/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $175 New Target: $185 Maintain
02/03/2018 Broker: Sandler O’Neill Rating: Buy New Target: $185.0 Maintain
26/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $168.0 Maintain
07/02/2018 Broker: Goldman Sachs Rating: Buy New Target: $180.0 Upgrade
02/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $161.0 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $173 New Target: $175 Maintain

The stock increased 0.02% or $0.03 during the last trading session, reaching $160.7.Currently CME Group Inc. is uptrending after 37.71% change in last May 17, 2017. CME has 809,992 shares volume. CME outperformed the S&P 500 by 26.16%.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.The firm is valued at $54.72 billion. The firm offers a range of products across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.The P/E ratio is 13.46. The Company’s products include exchange-traded; and privately negotiated futures and options contracts and swaps.

A couple more CME Group Inc. (NASDAQ:CME) news were posted by: Fool.com which released on April 27, 2018 “CME Group (CME) Q1 2018 Earnings Conference Call Transcript”, also Seekingalpha.com on May 08, 2018 posted “CME: Great Business, But Grossly Overvalued”, the next Fool.com is “CME Group Benefits From the Return of Market Volatility” on May 01, 2018. Nasdaq.com has article titled “3 Ways to Play Cryptocurrencies Without Actually Buying Them”.

CME Group Inc. (NASDAQ:CME) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.